knowledge -WSS

knowledge

author：entertainment 2025-09-06 02:06:12 - browse：3269

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Merck to acquire Harpoon Therapeutics for $680 million

WSS

Medicare solvency divides Republicans at the presidential debate

Boston Scientific acquires urology company Axonics for $3.7 billion

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

The Sacklers, horror, and ‘The Fall of the House of Usher’

Removing probiotics from the NICU could threaten preemies' health

Boston Scientific acquires urology company Axonics for $3.7 billion

Wikipedia

knowledge

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Gene therapy denied for Afghan refugee whose father aided U.S.

Medicare proposal to cover medical devices draws a mixed reaction

Merck to acquire Harpoon Therapeutics for $680 million

Hollywood unions extend contract negotiations for actors

Nonprofit, backed by Microsoft, to certify AI tools in health care

Hepatitis C has a cure — but many Americans still lack access to it

Study suggests new cause of Down syndrome: cells linked to aging

Affirmative action in medical school literally saved lives

Boston Scientific acquires urology company Axonics for $3.7 billion

Wikipedia

Stories you might have missed in 2023: health, science, medicine

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Study suggests new cause of Down syndrome: cells linked to aging

Nonprofit, backed by Microsoft, to certify AI tools in health care

Study: New antibiotic targets gonorrhea as well as last existing drug

Ambulance rides for just $100? Advisers want major billing fixes

entertainment

Wikipedia

hotspot

hotspot